Report Detail

Pharma & Healthcare Global Orally Dissolving Film Drug Market Growth 2022-2028

  • RnM4439570
  • |
  • 12 May, 2022
  • |
  • Global
  • |
  • 125 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Orally Dissolving Film Drug Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Orally Dissolving Film Drug by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Orally Dissolving Film Drug by Country/Region, 2017, 2022 & 2028
  • 2.2 Orally Dissolving Film Drug Segment by Type
    • 2.2.1 Orodispersible Film
    • 2.2.2 Oromucosal Film
  • 2.3 Orally Dissolving Film Drug Sales by Type
    • 2.3.1 Global Orally Dissolving Film Drug Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Orally Dissolving Film Drug Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Orally Dissolving Film Drug Sale Price by Type (2017-2022)
  • 2.4 Orally Dissolving Film Drug Segment by Application
    • 2.4.1 Hospitals
    • 2.4.2 Drugstores
    • 2.4.3 Others
  • 2.5 Orally Dissolving Film Drug Sales by Application
    • 2.5.1 Global Orally Dissolving Film Drug Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Orally Dissolving Film Drug Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Orally Dissolving Film Drug Sale Price by Application (2017-2022)

3 Global Orally Dissolving Film Drug by Company

  • 3.1 Global Orally Dissolving Film Drug Breakdown Data by Company
    • 3.1.1 Global Orally Dissolving Film Drug Annual Sales by Company (2020-2022)
    • 3.1.2 Global Orally Dissolving Film Drug Sales Market Share by Company (2020-2022)
  • 3.2 Global Orally Dissolving Film Drug Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Orally Dissolving Film Drug Revenue by Company (2020-2022)
    • 3.2.2 Global Orally Dissolving Film Drug Revenue Market Share by Company (2020-2022)
  • 3.3 Global Orally Dissolving Film Drug Sale Price by Company
  • 3.4 Key Manufacturers Orally Dissolving Film Drug Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Orally Dissolving Film Drug Product Location Distribution
    • 3.4.2 Players Orally Dissolving Film Drug Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Orally Dissolving Film Drug by Geographic Region

  • 4.1 World Historic Orally Dissolving Film Drug Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Orally Dissolving Film Drug Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Orally Dissolving Film Drug Annual Revenue by Geographic Region
  • 4.2 World Historic Orally Dissolving Film Drug Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Orally Dissolving Film Drug Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Orally Dissolving Film Drug Annual Revenue by Country/Region
  • 4.3 Americas Orally Dissolving Film Drug Sales Growth
  • 4.4 APAC Orally Dissolving Film Drug Sales Growth
  • 4.5 Europe Orally Dissolving Film Drug Sales Growth
  • 4.6 Middle East & Africa Orally Dissolving Film Drug Sales Growth

5 Americas

  • 5.1 Americas Orally Dissolving Film Drug Sales by Country
    • 5.1.1 Americas Orally Dissolving Film Drug Sales by Country (2017-2022)
    • 5.1.2 Americas Orally Dissolving Film Drug Revenue by Country (2017-2022)
  • 5.2 Americas Orally Dissolving Film Drug Sales by Type
  • 5.3 Americas Orally Dissolving Film Drug Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Orally Dissolving Film Drug Sales by Region
    • 6.1.1 APAC Orally Dissolving Film Drug Sales by Region (2017-2022)
    • 6.1.2 APAC Orally Dissolving Film Drug Revenue by Region (2017-2022)
  • 6.2 APAC Orally Dissolving Film Drug Sales by Type
  • 6.3 APAC Orally Dissolving Film Drug Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Orally Dissolving Film Drug by Country
    • 7.1.1 Europe Orally Dissolving Film Drug Sales by Country (2017-2022)
    • 7.1.2 Europe Orally Dissolving Film Drug Revenue by Country (2017-2022)
  • 7.2 Europe Orally Dissolving Film Drug Sales by Type
  • 7.3 Europe Orally Dissolving Film Drug Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Orally Dissolving Film Drug by Country
    • 8.1.1 Middle East & Africa Orally Dissolving Film Drug Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Orally Dissolving Film Drug Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Orally Dissolving Film Drug Sales by Type
  • 8.3 Middle East & Africa Orally Dissolving Film Drug Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Orally Dissolving Film Drug
  • 10.3 Manufacturing Process Analysis of Orally Dissolving Film Drug
  • 10.4 Industry Chain Structure of Orally Dissolving Film Drug

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Orally Dissolving Film Drug Distributors
  • 11.3 Orally Dissolving Film Drug Customer

12 World Forecast Review for Orally Dissolving Film Drug by Geographic Region

  • 12.1 Global Orally Dissolving Film Drug Market Size Forecast by Region
    • 12.1.1 Global Orally Dissolving Film Drug Forecast by Region (2023-2028)
    • 12.1.2 Global Orally Dissolving Film Drug Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Orally Dissolving Film Drug Forecast by Type
  • 12.7 Global Orally Dissolving Film Drug Forecast by Application

13 Key Players Analysis

  • 13.1 GSK
    • 13.1.1 GSK Company Information
    • 13.1.2 GSK Orally Dissolving Film Drug Product Offered
    • 13.1.3 GSK Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 GSK Main Business Overview
    • 13.1.5 GSK Latest Developments
  • 13.2 LTS
    • 13.2.1 LTS Company Information
    • 13.2.2 LTS Orally Dissolving Film Drug Product Offered
    • 13.2.3 LTS Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 LTS Main Business Overview
    • 13.2.5 LTS Latest Developments
  • 13.3 J&J
    • 13.3.1 J&J Company Information
    • 13.3.2 J&J Orally Dissolving Film Drug Product Offered
    • 13.3.3 J&J Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 J&J Main Business Overview
    • 13.3.5 J&J Latest Developments
  • 13.4 Indivior
    • 13.4.1 Indivior Company Information
    • 13.4.2 Indivior Orally Dissolving Film Drug Product Offered
    • 13.4.3 Indivior Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Indivior Main Business Overview
    • 13.4.5 Indivior Latest Developments
  • 13.5 Pfizer
    • 13.5.1 Pfizer Company Information
    • 13.5.2 Pfizer Orally Dissolving Film Drug Product Offered
    • 13.5.3 Pfizer Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Pfizer Main Business Overview
    • 13.5.5 Pfizer Latest Developments
  • 13.6 Sanofi
    • 13.6.1 Sanofi Company Information
    • 13.6.2 Sanofi Orally Dissolving Film Drug Product Offered
    • 13.6.3 Sanofi Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Sanofi Main Business Overview
    • 13.6.5 Sanofi Latest Developments
  • 13.7 Church & Dwight
    • 13.7.1 Church & Dwight Company Information
    • 13.7.2 Church & Dwight Orally Dissolving Film Drug Product Offered
    • 13.7.3 Church & Dwight Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Church & Dwight Main Business Overview
    • 13.7.5 Church & Dwight Latest Developments
  • 13.8 tesa Labtec
    • 13.8.1 tesa Labtec Company Information
    • 13.8.2 tesa Labtec Orally Dissolving Film Drug Product Offered
    • 13.8.3 tesa Labtec Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 tesa Labtec Main Business Overview
    • 13.8.5 tesa Labtec Latest Developments
  • 13.9 Tapemark
    • 13.9.1 Tapemark Company Information
    • 13.9.2 Tapemark Orally Dissolving Film Drug Product Offered
    • 13.9.3 Tapemark Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Tapemark Main Business Overview
    • 13.9.5 Tapemark Latest Developments
  • 13.10 Prestige
    • 13.10.1 Prestige Company Information
    • 13.10.2 Prestige Orally Dissolving Film Drug Product Offered
    • 13.10.3 Prestige Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Prestige Main Business Overview
    • 13.10.5 Prestige Latest Developments
  • 13.11 Sun Pharma
    • 13.11.1 Sun Pharma Company Information
    • 13.11.2 Sun Pharma Orally Dissolving Film Drug Product Offered
    • 13.11.3 Sun Pharma Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Sun Pharma Main Business Overview
    • 13.11.5 Sun Pharma Latest Developments
  • 13.12 MonoSol
    • 13.12.1 MonoSol Company Information
    • 13.12.2 MonoSol Orally Dissolving Film Drug Product Offered
    • 13.12.3 MonoSol Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 MonoSol Main Business Overview
    • 13.12.5 MonoSol Latest Developments
  • 13.13 BioDelivery
    • 13.13.1 BioDelivery Company Information
    • 13.13.2 BioDelivery Orally Dissolving Film Drug Product Offered
    • 13.13.3 BioDelivery Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 BioDelivery Main Business Overview
    • 13.13.5 BioDelivery Latest Developments
  • 13.14 Arx
    • 13.14.1 Arx Company Information
    • 13.14.2 Arx Orally Dissolving Film Drug Product Offered
    • 13.14.3 Arx Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Arx Main Business Overview
    • 13.14.5 Arx Latest Developments
  • 13.15 ZIM
    • 13.15.1 ZIM Company Information
    • 13.15.2 ZIM Orally Dissolving Film Drug Product Offered
    • 13.15.3 ZIM Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 ZIM Main Business Overview
    • 13.15.5 ZIM Latest Developments
  • 13.16 NAL Pharma
    • 13.16.1 NAL Pharma Company Information
    • 13.16.2 NAL Pharma Orally Dissolving Film Drug Product Offered
    • 13.16.3 NAL Pharma Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.16.4 NAL Pharma Main Business Overview
    • 13.16.5 NAL Pharma Latest Developments
  • 13.17 AdhexPharma
    • 13.17.1 AdhexPharma Company Information
    • 13.17.2 AdhexPharma Orally Dissolving Film Drug Product Offered
    • 13.17.3 AdhexPharma Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.17.4 AdhexPharma Main Business Overview
    • 13.17.5 AdhexPharma Latest Developments
  • 13.18 Aavishkar
    • 13.18.1 Aavishkar Company Information
    • 13.18.2 Aavishkar Orally Dissolving Film Drug Product Offered
    • 13.18.3 Aavishkar Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.18.4 Aavishkar Main Business Overview
    • 13.18.5 Aavishkar Latest Developments
  • 13.19 IntelGenx Corp
    • 13.19.1 IntelGenx Corp Company Information
    • 13.19.2 IntelGenx Corp Orally Dissolving Film Drug Product Offered
    • 13.19.3 IntelGenx Corp Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.19.4 IntelGenx Corp Main Business Overview
    • 13.19.5 IntelGenx Corp Latest Developments
  • 13.20 APR
    • 13.20.1 APR Company Information
    • 13.20.2 APR Orally Dissolving Film Drug Product Offered
    • 13.20.3 APR Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.20.4 APR Main Business Overview
    • 13.20.5 APR Latest Developments

14 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Orally Dissolving Film Drug will have significant change from previous year. According to our (LP Information) latest study, the global Orally Dissolving Film Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Orally Dissolving Film Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Orally Dissolving Film Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Orally Dissolving Film Drug market, reaching US$ million by the year 2028. As for the Europe Orally Dissolving Film Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Orally Dissolving Film Drug players cover GSK, LTS, J&J, and Indivior, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Orally Dissolving Film Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Orodispersible Film
Oromucosal Film

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Drugstores
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR


Summary:
Get latest Market Research Reports on Orally Dissolving Film Drug. Industry analysis & Market Report on Orally Dissolving Film Drug is a syndicated market report, published as Global Orally Dissolving Film Drug Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Orally Dissolving Film Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,935.32
5,870.64
3,466.02
6,932.04
469,029.00
938,058.00
284,931.00
569,862.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report